Document is current
Any future updates will be listed below
-
Authors
Haikarainen, Teemu https://orcid.org/0000-0002-8441-2517
Virtanen, Anniina T.
Cravatt, Benjamin F.
Silvennoinen, Olli https://orcid.org/0000-0003-0747-9512
- License Information
-
More Information
Article History
Accepted: 4 November 2025
First Online: 5 January 2026
Competing interests
: O.S. holds a patent on JAK kinases (US Patent 8,841,078) and is a co-founder and adviser for Ajax Therapeutics. B.F.C. is a founder and scientific adviser of Vividion Therapeutics and Magnet Therapeutics. The other authors declare no competing interests.
